A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Perspective Therapeutics
Incyte Corporation
NuCana plc
PharmaMar
Cancer Research UK
Aminex Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Rain Oncology Inc
Western Sydney Local Health District
Institut Bergonié
Incyte Corporation
Shenzhen BinDeBio Ltd.